"The market for personalized medicine in the United States is already $232 billion, and it is projected to grow 11 percent annually, reaching $452 billion by 2015." —John Norris, JD, MBA
Challenges in the Implementation of Appropriate Business Models for Personalized Medicine
|
- What will this new integrated model for pharmacogenetics and drug discovery look like?
- What Rx/Dx partnership incentives can we employ to achieve financial and equivalent goal congruence?
- What is the value of a biomarker that enables a therapy to an equivalent or higher ROI than OSFA?
- What pricing and outcomes models could be utilized to optimize the clinical benefit of targeted therapy and minimize the lag of diagnostic test adoption?
|
Mollie Roth, Esq.
Corporate Counsel; Vice President, Business Development
Diaceutics
|
|
Mara G. Aspinall, MBA
Chief Executive Officer
On-Q-ity
|
|
|
Andrea Lauber
Head, Technology Transactions for Clinical Biomarkers and Pharmacodiagnostics, Strategic Transactions Group
Bristol-Myers Squibb |
|
|
Noel Doheny
Principal, Noel Doheny, LLC;
Former Chief Executive Officer, OpGen |
The World Health Care Congress Leadership Summit on Personalized Health Care convenes senior level executives from hospitals, health systems, health plans and pharmaceutical companies to explore the evolution of personalized medicine from concept to main stream health care delivery. As personalized medicine has the potential to revolutionize medical care, this conference is created to bring together a wide variety of stakeholders in both the public and private sector to examine both the opportunities and challenges facing those involved in the development and realization of personalized medicine.
- UNCOVER the challenges in implementing an appropriate business model for personalized medicine
- DETERMINE the legal and ethical concerns associated with this new wave of diagnosis and treatment
- EVALUATE how value-based payments could accelerate adoption
- EXPLORE projected ROIs for targeted treatment and how this will impact the future delivery of care
- HEAR how molecular medicine is causing disruptive market changes and the opportunities being created
For general questions and Leadership Summit inquiries, contact:
Melynda Hilliard
Conference Manager
The World Health Care Congress Leadership Summit
on Personalized Health Care
Phone: 781-939-2624
Email:
[email protected]
To inquire about sponsorship and executive networking opportunities, contact:
Annie McKnight
Business Development Manager
The World Health Care Congress Leadership Summits
Phone: 781-939-2635
Email: [email protected]
To inquire about marketing opportunities, contact:
Andrea Chadis
Senior Marketing Manager
World Health Care Congress Leadership Summits
Tel: 781-939-2508
Email: [email protected]
Printer Friendly
Email A Colleague
Bookmark Page
